Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Long-Term Debt

Arena Pharmaceutical Long-Term Debt Chart (ARNA)

Arena Pharmaceutical annual/quarterly Long-Term Debt from 2000 to 2012.
  • Arena Pharmaceutical Long-Term Debt for the quarter ending March 03, 2012 was $12m a -6.08% decrease of -1m year over year
  • Arena Pharmaceutical Long-Term Debt for the last 12 months ending March 03, 2012 was $12m a -6.08% decrease of -1m year over year
  • Arena Pharmaceutical Annual Long-Term Debt for 2011 was $15m a -86.44% decrease of -13m from 2010
  • Arena Pharmaceutical Annual Long-Term Debt for 2010 was $27m a -122.17% decrease of -33m from 2009
  • Arena Pharmaceutical Annual Long-Term Debt for 2009 was $61m a 85.93% increase of 52m from 2008
Other Cash Flow Metrics:
  • Arena Pharmaceutical Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceutical Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Long-Term Debt Data

03/2012$12m
12/2011$15m
09/2011$14m
06/2011$13m
03/2011$12m
12/2010$27m
09/2010$26m
06/2010$56m
03/2010$60m
12/2009$61m

Annual ARNA Long-Term Debt Data

2011$15m
2010$27m
2009$61m
2008$9m
2004$13m
2003$13m
1999$1m